Skip to main content

Advertisement

Log in

Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Leptomeningeal metastasis (LM) is a severe complication in the natural history of malignancies that occurs in 4–15 % of patients (pts) with solid tumors. Clinical presentation, cerebrospinal fluid cytology (CSF), and gadolinium magnetic resonance imaging (gdMRI) of the brain and spine are the methods routinely used to diagnose LM. Treatment encompasses involved-field radiotherapy of bulky or symptomatic disease sites and chemotherapy; however, no standard therapy has been established yet. We collected and reviewed retrospectively the clinical, pathological, radiological findings as well as the outcomes of 50 consecutive patients with LM from solid tumors to determine whether the diagnostic modalities and therapeutic procedures affected the outcomes. The results of this study confirm the role of gdMRI in the diagnosis of LM in clinical practice and suggest that an aggressive treatment may improve survival in patients with this debilitating and increasingly frequent neurological complication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Chamberlain MC (1997) Carcinomatous meningitis. Arch Neurol 54:16–17

    Article  CAS  PubMed  Google Scholar 

  2. Glass JP, Melamed M, Chernik NL, Posner JB (1979) Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 29:1369–1375

    Article  CAS  PubMed  Google Scholar 

  3. Wasserstrom WR, Glass JP, Posner JB (2006) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49:759–772

    Article  Google Scholar 

  4. Chamberlain MC (2006) Neoplastic meningitis. Neurologist 12:179–187

    Article  PubMed  Google Scholar 

  5. Enting RH (2005) Leptomeningeal neoplasia: epidemiology, clinical presentation, CSF analysis and diagnostic imaging. Cancer Treat Res 125:17–30

    Article  PubMed  Google Scholar 

  6. Zeiser R, Burger JA, Bley TA, Windfuhr-Blum M, Schulte-Mönting J, Behringer DM (2004) Clinical follow-up indicates differential accuracy of magnetic resonance imaging and immunocytology of the cerebral spinal fluid for the diagnosis of neoplastic meningitis—a single centre experience. Br J Haematol 124(6):762–768

    Article  PubMed  Google Scholar 

  7. Chamberlain MC, Glantz M, Groves MD, Wilson WH (2009) Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol 36(4 Suppl 2):S35–S45

    Article  PubMed  Google Scholar 

  8. Jayson GC, Howell A (1996) Carcinomatous meningitis in solid tumours. Ann Oncol 7(8):773–786

    Article  CAS  PubMed  Google Scholar 

  9. Grossman SA, Krabak MJ (1999) Leptomeningeal carcinomatosis. Cancer Treat Rev 25:103–119

    Article  CAS  PubMed  Google Scholar 

  10. Chamberlain MC (2005) Neoplastic meningitis. J Clin Oncol 23(15):3605–3612

    Article  PubMed  Google Scholar 

  11. Clarke JL, Perez HR, Jacks LM, Panageas KS, De Angelis LM (2010) Leptomeningeal metastases in the MRI era. Neurology 74:1449–1454

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Rameri C, Silva de Azevedo A, Rocha Sousa Cruz M, Thome Domingos Chinen L, Verzinhasse Peres S, Aurélio Peterlevitz M et al (2011) Meningeal carcinomatosis in breast cancer: prognostic factors and outcome. Neurooncol 104:565–572

    Article  Google Scholar 

  13. Glantz MJ, Cole BF, Glantz LK, Cobb J, Mills P, Lekos A, Walters BC, REchts D (1998) Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 82:733–739

    Article  CAS  PubMed  Google Scholar 

  14. Chamberlain MC, Johnston SK (2009) Neoplastic meningitis: survival as a function of cerebrospinal fluid cytology. Cancer 115(9):1941–1946

    Article  PubMed  Google Scholar 

  15. Chamberlain MC, Sandy A, Press GA (1990) Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain. Neurology 40:435–438

    Article  CAS  PubMed  Google Scholar 

  16. Chamberlain MC, Kormanik P (1997) Prognostic significance of co-existent bulky metastatic central nervous system disease in patients with leptomeningeal metastases. Arch Neurol 54:1364–1368

    Article  CAS  PubMed  Google Scholar 

  17. Harstad L, Hess KR, Groves MD (2008) Prognostic factors and outcomes in patients with leptomeningeal melanomatosis. Neurooncology 10:1010–1018

    Google Scholar 

  18. Groves MD, Glantz MJ, Chamberlain MC, Baumgartner KE, Conrad CA, Hsu S, Wefel JS, Gilbert MR, Ictech S, Hunter KU, Forman AD, Puduvalli VK, Colman H, Hess KR, Yung WK (2008) A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies. Neurooncology 10:208–215

    CAS  Google Scholar 

  19. Balm M, Hammack J (1996) Leptomeningeal carcinomatosis: presenting features and prognostic factors. Arch Neurol 53:626–632

    Article  CAS  PubMed  Google Scholar 

  20. Waki F, Ando M, Takashima A, Yonemori K, Nokihara H, Miyake M, Tateishi U, Tsuta K, Shimada Y, Fujiwara Y, Tamura T (2009) Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol 93(2):205–212

    Article  PubMed  Google Scholar 

  21. Herrlinger U, Förschler H, Küker W, Meyermann R, Bamberg M, Dichgans J, Weller M (2004) Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci 223:167–178

    Article  PubMed  Google Scholar 

  22. Chamberlain M (2008) Neoplastic meningitis. Oncologist 13:967–977

    Article  PubMed  Google Scholar 

  23. Deisenhammer F et al (2010) European Handbook of Neurological Management, vol 1. Wiley-Blackwell, Chichester

    Google Scholar 

  24. Lin N, Dunn IF, Glantz M, Allison DL, Jensen R, Johnson MD, Friedlander RM, Kesari S (2011) Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study. Neurosurgery 115(4):730–736

    Article  Google Scholar 

Download references

Conflict of interest

All authors disclose any financial and personal relationships with other people or organisations that could inappropriately influence the work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rebecca Pedersini.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Passarin, M.G., Sava, T., Furlanetto, J. et al. Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. Neurol Sci 36, 117–123 (2015). https://doi.org/10.1007/s10072-014-1881-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-014-1881-7

Keywords

Navigation